NYHA Class Change Index Calculator

Clinical calculation support · Verify results before clinical use

Functional Class Assessment

Compare the patient's NYHA functional class before and after rehabilitation.

— Class change

Select the documented baseline functional class.

Use the same assessment approach and document the timing of reassessment.

How to interpret the change

The NYHA functional classification describes the extent to which cardiac symptoms limit physical activity. The class is ordinal: a lower class generally indicates fewer symptom-related activity limitations.

Calculated differenceInterpretation
Positive (>0)Improvement: the post-rehabilitation class number is lower.
ZeroNo change in the recorded NYHA class.
Negative (<0)Worsening: the post-rehabilitation class number is higher.

NYHA functional classes

  • Class I: No limitation of physical activity; ordinary activity does not cause undue symptoms.
  • Class II: Slight limitation; comfortable at rest, but ordinary activity causes symptoms.
  • Class III: Marked limitation; comfortable at rest, but less-than-ordinary activity causes symptoms.
  • Class IV: Symptoms at rest or inability to perform physical activity without symptoms.

Important measurement consideration

NYHA class is a clinician-rated, symptom-based measure. Its reproducibility may be limited; when comparing pre- and post-rehabilitation status, use consistent assessment methods and consider complementary measures such as exercise capacity and a validated health-status questionnaire.

References

Raphael C, Briscoe C, Davies J, et al. The limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93(4):476–482. DOI: 10.1136/hrt.2006.089656.
Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart & Lung. 2002;31(4):262–270. DOI: 10.1067/mhl.2002.124554.
Giustino G, Lindenfeld J, Abraham WT, et al. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial. JACC Cardiovasc Interv. 2020;13(20):2317–2328. DOI: 10.1016/j.jcin.2020.06.058.